These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 26983574)
1. Epigenetic silencing of miR-181c by DNA methylation in glioblastoma cell lines. Ayala-Ortega E; Arzate-Mejía R; Pérez-Molina R; González-Buendía E; Meier K; Guerrero G; Recillas-Targa F BMC Cancer; 2016 Mar; 16():226. PubMed ID: 26983574 [TBL] [Abstract][Full Text] [Related]
2. Tumor suppressor miR-181c attenuates proliferation, invasion, and self-renewal abilities in glioblastoma. Ruan J; Lou S; Dai Q; Mao D; Ji J; Sun X Neuroreport; 2015 Jan; 26(2):66-73. PubMed ID: 25494473 [TBL] [Abstract][Full Text] [Related]
3. Disruption of CTCF at the miR-125b1 locus in gynecological cancers. Soto-Reyes E; González-Barrios R; Cisneros-Soberanis F; Herrera-Goepfert R; Pérez V; Cantú D; Prada D; Castro C; Recillas-Targa F; Herrera LA BMC Cancer; 2012 Jan; 12():40. PubMed ID: 22277129 [TBL] [Abstract][Full Text] [Related]
4. Gain of DNA methylation is enhanced in the absence of CTCF at the human retinoblastoma gene promoter. Dávalos-Salas M; Furlan-Magaril M; González-Buendía E; Valdes-Quezada C; Ayala-Ortega E; Recillas-Targa F BMC Cancer; 2011 Jun; 11():232. PubMed ID: 21663659 [TBL] [Abstract][Full Text] [Related]
5. Dysregulation of miR-181c expression influences recurrence of endometrial endometrioid adenocarcinoma by modulating NOTCH2 expression: An NRG Oncology/Gynecologic Oncology Group study. Devor EJ; Miecznikowski J; Schickling BM; Gonzalez-Bosquet J; Lankes HA; Thaker P; Argenta PA; Pearl ML; Zweizig SL; Mannel RS; Brown A; Ramirez NC; Ioffe OB; Park KJ; Creasman WT; Birrer MJ; Mutch D; Leslie KK Gynecol Oncol; 2017 Dec; 147(3):648-653. PubMed ID: 28969912 [TBL] [Abstract][Full Text] [Related]
6. The tumor suppressor microRNA, miR-124a, is regulated by epigenetic silencing and by the transcriptional factor, REST in glioblastoma. Tivnan A; Zhao J; Johns TG; Day BW; Stringer BW; Boyd AW; Tiwari S; Giles KM; Teo C; McDonald KL Tumour Biol; 2014 Feb; 35(2):1459-65. PubMed ID: 24068568 [TBL] [Abstract][Full Text] [Related]
7. Epigenetic regulation of the human retinoblastoma tumor suppressor gene promoter by CTCF. De La Rosa-Velázquez IA; Rincón-Arano H; Benítez-Bribiesca L; Recillas-Targa F Cancer Res; 2007 Mar; 67(6):2577-85. PubMed ID: 17363576 [TBL] [Abstract][Full Text] [Related]
8. Epigenetic Modification of MicroRNA-205 and its Association with Glioblastoma Multiform. Ghasemi A; Fallah S Clin Lab; 2017 Jul; 63(7):1079-1088. PubMed ID: 28792704 [TBL] [Abstract][Full Text] [Related]
9. Epigenetic regulation of the human p53 gene promoter by the CTCF transcription factor in transformed cell lines. Soto-Reyes E; Recillas-Targa F Oncogene; 2010 Apr; 29(15):2217-27. PubMed ID: 20101205 [TBL] [Abstract][Full Text] [Related]
10. The dual specificity phosphatase 2 gene is hypermethylated in human cancer and regulated by epigenetic mechanisms. Haag T; Richter AM; Schneider MB; Jiménez AP; Dammann RH BMC Cancer; 2016 Feb; 16():49. PubMed ID: 26833217 [TBL] [Abstract][Full Text] [Related]
11. Disruption of CTCF/cohesin-mediated high-order chromatin structures by DNA methylation downregulates PTGS2 expression. Kang JY; Song SH; Yun J; Jeon MS; Kim HP; Han SW; Kim TY Oncogene; 2015 Nov; 34(45):5677-84. PubMed ID: 25703332 [TBL] [Abstract][Full Text] [Related]
12. Epigenetic silencing of the XAF1 gene is mediated by the loss of CTCF binding. Victoria-Acosta G; Vazquez-Santillan K; Jimenez-Hernandez L; Muñoz-Galindo L; Maldonado V; Martinez-Ruiz GU; Melendez-Zajgla J Sci Rep; 2015 Oct; 5():14838. PubMed ID: 26443201 [TBL] [Abstract][Full Text] [Related]
13. CTCF mediates the TERT enhancer-promoter interactions in lung cancer cells: identification of a novel enhancer region involved in the regulation of TERT gene. Eldholm V; Haugen A; Zienolddiny S Int J Cancer; 2014 May; 134(10):2305-13. PubMed ID: 24174344 [TBL] [Abstract][Full Text] [Related]
14. DNMT1 and EZH2 mediated methylation silences the microRNA-200b/a/429 gene and promotes tumor progression. Ning X; Shi Z; Liu X; Zhang A; Han L; Jiang K; Kang C; Zhang Q Cancer Lett; 2015 Apr; 359(2):198-205. PubMed ID: 25595591 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-181c inhibits glioblastoma cell invasion, migration and mesenchymal transition by targeting TGF-β pathway. He X; Liu Z; Peng Y; Yu C Biochem Biophys Res Commun; 2016 Jan; 469(4):1041-8. PubMed ID: 26682928 [TBL] [Abstract][Full Text] [Related]
16. Epigenetic repression of RARRES1 is mediated by methylation of a proximal promoter and a loss of CTCF binding. Peng Z; Shen R; Li YW; Teng KY; Shapiro CL; Lin HJ PLoS One; 2012; 7(5):e36891. PubMed ID: 22615834 [TBL] [Abstract][Full Text] [Related]
17. Involvement of epigenetically silenced microRNA-181c in gastric carcinogenesis. Hashimoto Y; Akiyama Y; Otsubo T; Shimada S; Yuasa Y Carcinogenesis; 2010 May; 31(5):777-84. PubMed ID: 20080834 [TBL] [Abstract][Full Text] [Related]
18. Extensive modulation of a set of microRNAs in primary glioblastoma. Ciafrè SA; Galardi S; Mangiola A; Ferracin M; Liu CG; Sabatino G; Negrini M; Maira G; Croce CM; Farace MG Biochem Biophys Res Commun; 2005 Sep; 334(4):1351-8. PubMed ID: 16039986 [TBL] [Abstract][Full Text] [Related]
19. Reciprocal binding of CTCF and BORIS to the NY-ESO-1 promoter coincides with derepression of this cancer-testis gene in lung cancer cells. Hong JA; Kang Y; Abdullaev Z; Flanagan PT; Pack SD; Fischette MR; Adnani MT; Loukinov DI; Vatolin S; Risinger JI; Custer M; Chen GA; Zhao M; Nguyen DM; Barrett JC; Lobanenkov VV; Schrump DS Cancer Res; 2005 Sep; 65(17):7763-74. PubMed ID: 16140944 [TBL] [Abstract][Full Text] [Related]
20. Epigenetic silencing of miRNA-9 is correlated with promoter-proximal CpG island hypermethylation in gastric cancer in vitro and in vivo. Li Y; Xu Z; Li B; Zhang Z; Luo H; Wang Y; Lu Z; Wu X Int J Oncol; 2014 Dec; 45(6):2576-86. PubMed ID: 25270964 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]